Bydureon (Exenatide) Once-Weekly Injectable Diabetes Drug Rebuffed By FDA Again
Links shared publicly online about this topic.
- 787total visits
Bydureon (Exenatide) Once-Weekly Injectable Diabetes Drug Rebuffed By FDA Again
The bid to get Byetta (exenatide) once-weekly version for diabetes treatment approval from the FDA (Food and Drug Administration) has failed for a second time Amylin Pharmaceuticals, Inc., Eli Lil
View full resource at medicalnewstoday.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Pharma, FDA, Byetta
Most Recently Shared on October 21, 2010 at 1:05 am By:
Bydureon (Exenatide) Once-Weekly Injectable Diabetes Drug Rebuffed By FDA Again http://mnt.to/3Lxc #regulatory
Also Shared By:
Advertisement
medical_tweets
@medical_tweets
Bydureon (Exenatide) Once-Weekly Injectable Diabetes Drug Rebuffed By FDA Again The bid to get Byetta (exenatide) once-.. http://dld.bz/2zZh
1 year ago...